UCLA, Caltech research on immune-cell therapy could strengthen promising melanoma treatment
- Posted: March 22, 2013
A new study of genetically modified immune cells by scientists from UCLA (home of the Jonsson Comprehensive Cancer Center) and the California Institute of Technology could help improve a promising treatment for melanoma, an often fatal form of skin cancer.
Among the research institutions NCI funds across the United States, it currently designates 67 as Cancer Centers. Largely based in research universities, these facilities are home to many of the NCI-supported scientists who conduct a wide range of intense, laboratory research into cancer’s origins and development. The Cancer Centers Program also focuses on trans-disciplinary research, including population science and clinical research. The centers’ research results are often at the forefront of studies in the cancer field.